Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
S-adenosyl-L-methionine + cytosine38 in tRNA
S-adenosyl-L-homocysteine + 5-methylcytosine38 in tRNA
S-adenosyl-L-methionine + cytosine38 in tRNAAsp
S-adenosyl-L-homocysteine + 5-methylcytosine38 in tRNAAsp
-
-
-
?
S-adenosyl-L-methionine + cytosine38 in tRNA
S-adenosyl-L-homocysteine + 5-methylcytosine38 in tRNA
-
in vitro transcribed tRNAAsp is methylated by DNMT2, albeit at reduced efficiency. Human, mouse, and Dictyostelium tRNA all are substrates for human DNMT2. C79, E119, R160 and R162 are essential for the catalytic mechanism of DNMT2
-
-
?
S-adenosyl-L-methionine + cytosine38 in tRNAAsp
S-adenosyl-L-homocysteine + 5-methylcytosine38 in tRNAAsp
S-adenosyl-L-methionine + cytosine38 in tRNAAsp precursor
S-adenosyl-L-homocysteine + 5-methylcytosine38 in tRNAAsp precursor
-
-
-
-
?
S-adenosyl-L-methionine + cytosine38 in tRNAGly precursor
S-adenosyl-L-homocysteine + 5-methylcytosine38 in tRNAGly precursor
-
-
-
-
?
S-adenosyl-L-methionine + cytosine38 in tRNAVal precursor
S-adenosyl-L-homocysteine + 5-methylcytosine38 in tRNAVal precursor
-
-
-
-
?
additional information
?
-
S-adenosyl-L-methionine + cytosine38 in tRNA
S-adenosyl-L-homocysteine + 5-methylcytosine38 in tRNA
-
-
-
?
S-adenosyl-L-methionine + cytosine38 in tRNA
S-adenosyl-L-homocysteine + 5-methylcytosine38 in tRNA
methylates tRNAAsp specifically at cytosine38 in the anticodon loop. Human DNMT2 protein restores methylation in vitro to tRNAAsp from Dnmt2-deficient strains of mouse, Arabidopsis thaliana, and Drosophila melanogaster in a manner that is dependent on preexisting patterns of modified nucleosides. Unmodified tRNAAsp produced by in vitro transcription is not a substrate for DNMT2, which suggests that methylation is guided to cytosine38 by other modifications. Mannosylqueuosine is likely to be involved, because it is unique to tRNAAsp. Analysis of tRNAAsp sequences show complete conservation of the anticodon loop in species whose genomes encode Dnmt2 homologs, but the tRNAAsp anticodon loops in Caenorhabditis elegans and Saccharomyces cerevisiae, which lack Dnmt2 homologs, have diverged
-
-
?
S-adenosyl-L-methionine + cytosine38 in tRNAAsp
S-adenosyl-L-homocysteine + 5-methylcytosine38 in tRNAAsp
-
-
-
-
?
S-adenosyl-L-methionine + cytosine38 in tRNAAsp
S-adenosyl-L-homocysteine + 5-methylcytosine38 in tRNAAsp
-
mapping of the tRNA binding site of DNMT2 by systematically mutating surface-exposed lysine and arginine residues to alanine and studying the tRNA methylation activity and binding of the corresponding variants. tRNA specificity determinants and tRNA binding pocket structure in the DNMT2, overview
-
-
?
additional information
?
-
DNMT2 is able to methylate the cytosine 38 in the anticodon loop of aspartic acid transfer RNA instead of transferring methyl groups to the cytosine residues in the genomic DNA
-
-
-
additional information
?
-
-
DNMT2 induces a conformational change in the tRNA of the DNMT2-tRNA complex
-
-
?
additional information
?
-
-
DNMT2 functions primarily, if not exclusively, as a cytosine 5-methylation RNA methyltransferase with three verified tRNA targets: tRNAAsp, tRNAGly and tRNAVal
-
-
?
additional information
?
-
-
the enzyme DNMT2 is responsible for methylation of cytosine 38 in the anticodon loop of aspartic acid transfer RNA instead of transferring methyl group to the cytosine residues of DNA
-
-
?
additional information
?
-
-
development and evaluation of 5-azacytidine-mediated RNA immunoprecipitation, a mechanism-based technique in nine steps that exploits the covalent bond formed between an RNA methyltransferase and the cytidine analogue 5-azacytidine to recover RNA targets by immunoprecipitation, overview. High frequency of C>G transversions at the cytosine residues targeted by the enzyme, allowing identification of the specific methylated cytosine(s) in target RNAs. tRNAGly(GCC) bears one DNMT2 target site (C38)
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
S-adenosyl-L-methionine + cytosine38 in tRNA
S-adenosyl-L-homocysteine + 5-methylcytosine38 in tRNA
-
-
-
?
S-adenosyl-L-methionine + cytosine38 in tRNAAsp
S-adenosyl-L-homocysteine + 5-methylcytosine38 in tRNAAsp
-
-
-
?
S-adenosyl-L-methionine + cytosine38 in tRNAAsp
S-adenosyl-L-homocysteine + 5-methylcytosine38 in tRNAAsp
-
-
-
-
?
S-adenosyl-L-methionine + cytosine38 in tRNAAsp precursor
S-adenosyl-L-homocysteine + 5-methylcytosine38 in tRNAAsp precursor
-
-
-
-
?
S-adenosyl-L-methionine + cytosine38 in tRNAGly precursor
S-adenosyl-L-homocysteine + 5-methylcytosine38 in tRNAGly precursor
-
-
-
-
?
S-adenosyl-L-methionine + cytosine38 in tRNAVal precursor
S-adenosyl-L-homocysteine + 5-methylcytosine38 in tRNAVal precursor
-
-
-
-
?
additional information
?
-
additional information
?
-
-
DNMT2 functions primarily, if not exclusively, as a cytosine 5-methylation RNA methyltransferase with three verified tRNA targets: tRNAAsp, tRNAGly and tRNAVal
-
-
?
additional information
?
-
-
the enzyme DNMT2 is responsible for methylation of cytosine 38 in the anticodon loop of aspartic acid transfer RNA instead of transferring methyl group to the cytosine residues of DNA
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Adenocarcinoma of Lung
RNA methyltransferase METTL3 induces intrinsic resistance to gefitinib by combining with MET to regulate PI3K/AKT pathway in lung adenocarcinoma.
Bone Resorption
Circ_0008542 in osteoblast exosomes promotes osteoclast-induced bone resorption through m6A methylation.
Breast Neoplasms
BCDIN3D RNA methyltransferase stimulates Aldolase C expression and glycolysis through let-7 microRNA in breast cancer cells.
Breast Neoplasms
Elevated expression of RNA methyltransferase BCDIN3D predicts poor prognosis in breast cancer.
Breast Neoplasms
Human BCDIN3D monomethylates cytoplasmic histidine transfer RNA.
Carcinogenesis
METTL14 facilitates global genome repair and suppresses skin tumorigenesis.
Carcinoma
RNA methyltransferase NSUN2 promotes hypopharyngeal squamous cell carcinoma proliferation and migration by enhancing TEAD1 expression in an m5C-dependent manner.
Carcinoma, Ehrlich Tumor
Recognition of the ribosomal RNA structures by purified nucleolar RNA methyltransferase.
Carcinoma, Hepatocellular
RNA methyltransferase NSUN2 promotes growth of hepatocellular carcinoma cells by regulating fizzy-related-1 in vitro and in vivo.
Carcinoma, Hepatocellular
The ATF/CREB site is the key element for transcription of the human RNA methyltransferase like 1(RNMTL1) gene, a newly discovered 17p13.3 gene.
Carcinoma, Hepatocellular
The Role of RNA Methyltransferase METTL3 in Hepatocellular Carcinoma: Results and Perspectives.
Carcinoma, Hepatocellular
[METTL14 as a predictor of postoperative survival outcomes of patients with hepatocellular carcinoma].
Carcinoma, Non-Small-Cell Lung
The RNA Methyltransferase NSUN2 and Its Potential Roles in Cancer.
Cystic Fibrosis
Identification of Aminoglycoside-resistant Pseudomonas aeruginosa producing RmtG 16S ribosomal RNA methyltransferase in a cystic fibrosis patient.
Gastrointestinal Neoplasms
Emerging role of RNA methyltransferase METTL3 in gastrointestinal cancer.
Glioma
Epigenetic loss of RNA-methyltransferase NSUN5 in glioma targets ribosomes to drive a stress adaptive translational program.
Hearing Loss
Auditory Pathology in a Transgenic mtTFB1 Mouse Model of Mitochondrial Deafness.
Infections
Temperature-dependent survival of Turnip crinkle virus-infected arabidopsis plants relies on an RNA silencing-based defense that requires dcl2, AGO2, and HEN1.
Intellectual Disability
Mutation in NSUN2, which encodes an RNA methyltransferase, causes autosomal-recessive intellectual disability.
Lung Neoplasms
The RNA Methyltransferase NSUN2 and Its Potential Roles in Cancer.
Neoplasm Metastasis
NSUN2 modified by SUMO-2/3 promotes gastric cancer progression and regulates mRNA m5C methylation.
Neoplasms
METTL3 expression is associated with glycolysis metabolism and sensitivity to glycolytic stress in hepatocellular carcinoma.
Neoplasms
METTL3?mediated m6A modification of Bcl?2 mRNA promotes non?small cell lung cancer progression.
Neoplasms
NSUN2 modified by SUMO-2/3 promotes gastric cancer progression and regulates mRNA m5C methylation.
Neoplasms
Overexpression of NSUN2 by DNA hypomethylation is associated with metastatic progression in human breast cancer.
Neoplasms
Recognition of the ribosomal RNA structures by purified nucleolar RNA methyltransferase.
Neoplasms
Regulation of telomere homeostasis and genomic stability in cancer by N 6-adenosine methylation (m6A).
Neoplasms
RNA methyltransferase NSUN2 promotes gastric cancer cell proliferation by repressing p57Kip2 by an m5C-dependent manner.
Neoplasms
RNA methyltransferase NSUN2 promotes hypopharyngeal squamous cell carcinoma proliferation and migration by enhancing TEAD1 expression in an m5C-dependent manner.
Neoplasms
The Critical Role of RNA m6A Methylation in Cancer.
Neoplasms
The RNA methyltransferase Misu (NSun2) mediates Myc-induced proliferation and is upregulated in tumors.
Neoplasms
The RNA Methyltransferase NSUN2 and Its Potential Roles in Cancer.
Neoplasms
Ubiquitination-mediated degradation of TRDMT1 regulates homologous recombination and therapeutic response.
Neoplasms
Virion-associated and cellular RNA methylase activity in normal and neoplastic mammary tissue from mammary tumor virus-infected and -uninfected mice.
Osteoarthritis
METTL3 promotes experimental osteoarthritis development by regulating inflammatory response and apoptosis in chondrocyte.
Pancreatic Neoplasms
The RNA methyltransferase NSUN6 suppresses pancreatic cancer development by regulating cell proliferation.
Spinal Dysraphism
An association study of 45 folate-related genes in spina bifida: Involvement of cubilin (CUBN) and tRNA aspartic acid methyltransferase 1 (TRDMT1).
Squamous Cell Carcinoma of Head and Neck
RNA methyltransferase NSUN2 promotes hypopharyngeal squamous cell carcinoma proliferation and migration by enhancing TEAD1 expression in an m5C-dependent manner.
Stomach Neoplasms
RNA methyltransferase NSUN2 promotes gastric cancer cell proliferation by repressing p57Kip2 by an m5C-dependent manner.
Tuberculosis
A Novel Motif for S-Adenosyl-l-methionine Binding by the Ribosomal RNA Methyltransferase TlyA from Mycobacterium tuberculosis.
Wilms Tumor
mTORC1 promotes cell growth via m6A-dependent mRNA degradation.
Wilms Tumor
mTORC1 stimulates cell growth through SAM synthesis and m6A mRNA-dependent control of protein synthesis.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
evolution
the DNMTs encompass three different structural regions: N-terminal regulatory domain, C-terminal catalytic domain and a central linker region. The N-terminal regulatory domain is particularly implicated in determining subcellular localization of the DNMT and in allocating unmethylated DNA strands from hemi-methylated ones. The C-terminal catalytic domain consists of 10 different characteristic motifs, and six of them (I, IV, VI, VIII, IX and X) are evolutionally conserved among mammals. General structure of mammalian DNA methyltransferases (DNMTs), overview. DNMT2 shows structural and functional differences when compared with the other DNMTs, it does not include N-terminal domain, and therefore cannot contribute to de-novo or maintenance methylation process
metabolism
analysis of aminoacylation of C38-methylated and unmethylated tRNAAsp
malfunction
-
the enzyme knockout causes disruption of RNA methyltransferase activity
physiological function
Dnmt2 RNA methyltransferase catalyses the methylation of C38 in the anticodon loop of tRNA-Asp. Cytosine methylation of tRNA-Asp by DNMT2 has a role in translation of proteins containing poly-Asp sequences. Proteins containing poly-Asp sequences in the human proteome often have roles in transcriptional regulation and gene expression. Hence, the Dnmt2-mediated methylation of tRNA-Asp exhibits a post-transcriptional regulatory role by controlling the synthesis of a group of target proteins containing poly-Asp sequences. Cytosine-38 methylation of tRNAAsp increases the rate of its aminoacylation
physiological function
enzyme DNMT2 carries out methylation of the cytosine 38 in the anticodon loop of aspartic acid transfer RNA. It is not involved in spermatogenesis
evolution
-
DNMT2 methylates RNA by employing a DNA methyltransferase-like catalytic mechanism, which is clearly different from the mechanism of other RNA MTases. DNMT2 has changed its substrate specificity from DNA to RNA in the course of its evolution
evolution
-
DNMT2 exhibits different expression patterns in different mammalian species. General structure of mammalian DNMTs: the enzymes are composed of three main parts: N-terminal regulatory domain, central linker region, and C-terminal catalytic domain. The N-terminal regulatory domain includes the following subdomains: charge rich-region, proliferating cell nuclear antigen-binding, nuclear localization signal, cytosine-rich zinc finger DNA-binding, polybromo homology, and tetrapeptide chromatin binding. The C-terminal catalytic domain includes six conserved motifs: the motif I contains an AdoMet binding site, the motif IV binds to substrate cytosine at its active site, the motif VI involves glutamyl residues serving as a donor, the motif IX maintains stability of the substrate-binding site, and the motif X functions in formation of the AdoMet binding site. DNMT2 is structurally and functionally different from other DNMTs because it does not possess the N-terminal regulatory domain
evolution
-
the enzyme belongs to the DNMT2 family of cytosine 5-methylation-RNA methyltransferases utilizing only one cysteine in their catalytic pocket
evolution
-
the enzyme is a highly conserved cytosine-C5 methyltransferase that introduces the C38 methylation of tRNA-Asp in many species, including lower eukaryotes, plants, insects and humans
physiological function
-
The DNMT2 protein methylates C38 of tRNA-Asp and it has a role in cellular physiology and stress response and its expression levels are altered in cancer tissues
physiological function
-
though DNMT2 has a catalytic domain at its C-terminus, it cannot catalyze either de novo or maintenance methylation process due to the absence of the N-terminal domain that enables other DNMT enzymes to bind DNA sequences and other regulatory proteins. DNMT2 is responsible for methylation of cytosine 38 in the anticodon loop of aspartic acid transfer RNA instead of transferring methyl group to the cytosine residues of DNA
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
C292A
-
about 3fold reduction in RNA binding affinity. Significant residual activity
D217H
-
site-directed mutagenesis, the mutant shows activity similar to the wild-type enzyme
D226Y
-
site-directed mutagenesis, the mutant shows activity similar to the wild-type enzyme
D255Y
-
site-directed mutagenesis, the mutant shows activity similar to the wild-type enzyme
E185K
-
site-directed mutagenesis, the mutant shows activity similar to the wild-type enzyme
E202Q
-
site-directed mutagenesis, the mutant shows activity similar to the wild-type enzyme
E317G
-
site-directed mutagenesi, the mutant shows activity similar to the wild-type enzyme
E63K
-
site-directed mutagenesis, the mutation causes a twofold increase in activity compared to the wild-type enzyme
G155S
-
site-directed mutagenesis, the mutation causes an over fourfold decrease in activity compared to the wild-type enzyme
G155V
-
site-directed mutagenesis, almost inactive mutant
K122A
-
site-directed mutagenesis, the mutant shows highly reduced activity compared to the wild-type enzyme
K168A
-
site-directed mutagenesis, the mutant shows only slightly reduced activity compared to the wild-type enzyme
K196A
-
site-directed mutagenesis, the mutant shows only slightly reduced activity compared to the wild-type enzyme
K241A
-
site-directed mutagenesis, the mutant shows moderately reduced activity compared to the wild-type enzyme
K251A
-
site-directed mutagenesis, the mutant shows moderately reduced activity compared to the wild-type enzyme
K254A
-
site-directed mutagenesis, the mutant shows only slightly reduced activity compared to the wild-type enzyme
K271A
-
site-directed mutagenesis, the mutant shows only slightly reduced activity compared to the wild-type enzyme
K295A
-
site-directed mutagenesis, the mutant shows highly reduced activity compared to the wild-type enzyme
K346A
-
site-directed mutagenesis, the mutant shows only slightly reduced activity compared to the wild-type enzyme
K363A
-
site-directed mutagenesis, the mutant shows only slightly reduced activity compared to the wild-type enzyme
K367A
-
site-directed mutagenesis, the mutant shows highly reduced activity compared to the wild-type enzyme
K387A
-
site-directed mutagenesis, the mutant shows only slightly reduced activity compared to the wild-type enzyme
L257V
-
site-directed mutagenesis, the mutation causes an over fourfold decrease in activity compared to the wild-type enzyme
M72I
-
site-directed mutagenesis, the mutant shows activity similar to the wild-type enzyme
N264S
-
site-directed mutagenesi, the mutant shows activity similar to the wild-type enzyme
R240A
-
site-directed mutagenesis, the mutant shows only slightly reduced activity compared to the wild-type enzyme
R275A
-
site-directed mutagenesis, the mutant shows highly reduced activity compared to the wild-type enzyme
R288A
-
site-directed mutagenesis, the mutant shows moderately reduced activity compared to the wild-type enzyme
R289A
-
site-directed mutagenesis, the mutant shows highly reduced activity compared to the wild-type enzyme
R369A
-
site-directed mutagenesis, the mutant shows moderately reduced activity compared to the wild-type enzyme
R371A
-
site-directed mutagenesis, the mutant shows highly reduced activity compared to the wild-type enzyme
R371H
-
site-directed mutagenesis, almost inactive mutant
R84A
-
site-directed mutagenesis, the mutant shows highly reduced activity compared to the wild-type enzyme
R95A
-
site-directed mutagenesis, the mutant shows highly reduced activity compared to the wild-type enzyme
C79A
-
site-directed mutagenesis, inactive mutant
C79A
-
about 3fold reduction in RNA binding affinity. No detectable in vitro methylation activity
E119A
-
site-directed mutagenesis, inactive mutant
E119A
-
mutant binds stronger to RNA than wild-type. No detectable in vitro methylation activity
R160A
-
site-directed mutagenesis, inactive mutant
R160A
-
no detectable in vitro methylation activity
R162A
-
site-directed mutagenesis, inactive mutant
R162A
-
no detectable in vitro methylation activity
additional information
generation of Dnmt2 knockout (KO) cells
additional information
-
generation of Dnmt2 knockout (KO) cells
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Jurkowski, T.P.; Meusburger, M.; Phalke, S.; Helm, M.; Nellen, W.; Reuter, G.; Jeltsch, A.
Human DNMT2 methylates tRNA(Asp) molecules using a DNA methyltransferase-like catalytic mechanism
RNA
14
1663-1670
2008
Drosophila melanogaster, Homo sapiens
brenda
Goll, M.G.; Kirpekar, F.; Maggert, K.A.; Yoder, J.A.; Hsieh, C.L.; Zhang, X.; Golic, K.G.; Jacobsen, S.E.; Bestor, T.H.
Methylation of tRNAAsp by the DNA methyltransferase homolog Dnmt2
Science
311
395-398
2006
Homo sapiens (O14717), Homo sapiens
brenda
Jurkowski, T.P.; Shanmugam, R.; Helm, M.; Jeltsch, A.
Mapping the tRNA binding site on the surface of human DNMT2 methyltransferase
Biochemistry
51
4438-4444
2012
Homo sapiens
brenda
Elhardt, W.; Shanmugam, R.; Jurkowski, T.P.; Jeltsch, A.
Somatic cancer mutations in the DNMT2 tRNA methyltransferase alter its catalytic properties
Biochimie
112
66-72
2015
Homo sapiens
brenda
Uysal, F.; Akkoyunlu, G.; Ozturk, S.
Dynamic expression of DNA methyltransferases (DNMTs) in oocytes and early embryos
Biochimie
116
103-113
2015
Bos taurus, Homo sapiens, Mus musculus (O55055)
brenda
Khoddami, V.; Cairns, B.R.
Identification of direct targets and modified bases of RNA cytosine methyltransferases
Nat. Biotechnol.
31
458-464
2013
Homo sapiens
brenda
Shanmugam, R.; Fierer, J.; Kaiser, S.; Helm, M.; Jurkowski, T.P.; Jeltsch, A.
Cytosine methylation of tRNA-Asp by DNMT2 has a role in translation of proteins containing poly-Asp sequences
Cell Discov.
1
15010
2015
Homo sapiens (O14717), Homo sapiens, Mus musculus (O55055), Mus musculus
brenda
Uysal, F.; Akkoyunlu, G.; Ozturk, S.
DNA methyltransferases exhibit dynamic expression during spermatogenesis
Reprod. Biomed. Online
33
690-702
2016
Homo sapiens (O14717), Mus musculus (O55055)
brenda